Table 1. Summary of characteristics of COVID-19 patients required management in an outpatient vs. hospital setting.
| Hospitalized (n = 545,635) | Outpatient (n = 1,360,078) | P Values | |
|---|---|---|---|
| Sex, No (%) | <0.001 | ||
| Female | 259,269 (47.5) | 763,133 (56.1) | |
| Male | 286,324 (52.5) | 596,660 (43.9) | |
| Age group, No. (%) | <0.001 | ||
| 18–30 | 35,607 (6.5) | 295,112 (21.7) | |
| 31–50 | 101,753 (18.6) | 464,876 (34.2) | |
| 51–64 | 141,501 (25.9) | 325,762 (24.0) | |
| 65–74 | 116,393 (21.3) | 156,462 (11.5) | |
| ≥ 75 | 150,381 (27.6) | 117,866 (8.7) | |
| Race/Ethnicity, No. (%) | <0.001 | ||
| White | 299,081 (54.8) | 785,383 (57.7) | |
| Black | 121,331(22.2) | 250,355 (18.4) | |
| Asian | 18,553 (3.4) | 39,988 (2.9) | |
| Hispanic* | 107,431 (19.7) | 258,132 (19.0) | |
| Other | 106,670 (19.5) | 284,352 (20.9) | |
| Payer, No. (%) | <0.001 | ||
| Commercial | 136,182 (25.0) | 716,643 (52.7) | |
| Medicare/Medicaid/State-assisted | 386,907 (70.9) | 611,203 (44.9) | |
| Other | 22,543 (4.1) | 32,232 (2.4) | |
| Existing comorbidities, No. (%) | |||
| Obesity | 156,645 (28.7) | 34,929 (2.6) | <0.001 |
| Hypertension | 341,525 (62.6) | 154,305 (11.3) | <0.001 |
| Diabetes | 208,711 (38.3) | 115,411 (8.5) | <0.001 |
| Anemia | 113,675 (20.8) | 5,984 (0.44) | <0.001 |
| Chronic pulmonary disease | 118,176 (21.7) | 19,201 (1.4) | <0.001 |
| Renal failure | 116,063 (21.3) | 9,438 (0.69) | <0.001 |
| Congestive heart failure | 86,764 (15.9) | 18,651 (1.4) | <0.001 |
| Liver disease | 28,682 (5.3) | 8,371 (0.62) | <0.001 |
| Valvular disease | 25,856 (4.7) | 163 (0.02) | <0.001 |
| Peripheral vascular disease | 23,039 (4.2) | 1915 (0.14) | <0.001 |
† Chi-square tests.
* Including White Hispanic, Black Hispanic, Asian Hispanic, and other Hispanic.